The healthcare sector's path forward? It's undeniably sustainable. Global pharmaceutical companies have evolved enough to integrate environmental, social, and governance (ESG) standards into their operations, and the region is bound to follow. The role of responsible business practices in this sector has simply become an imperative.
Bosnalijek, the largest pharmaceutical company in Bosnia and Herzegovina, and one of the largest in the region is a shining example of this transition. The company integrates sustainability standards at the very heart of its operations, boasts innovative product design practices, and a shining corporate culture.
This year they will reaffirm their values by supporting ESG Adria Summit 2025. This partnership is a reflection of Bosnalijek's commitment to building a healthier, more responsible future.
A Legacy of Sustainability
For decades, Bosnalijek has been demonstrating a profound understanding of its role in a thriving society and environmental well-being:
Regional pioneers of ESG Reporting: Bosnalijek has taken a leading role in the Adria region in terms of sustainability reporting. The company has published its Sustainability (ESG) Report, providing transparent insights into its sustainable activities that are aligned with GRI standards. This is the greatest testament to their aspiration to remain accountable and sets a benchmark for others in the industry.
- Award-Winning leadership: Bosnalijek was recognised as a Business Leader in Sustainable Development in BiH for 2024, in the "Resources and Environment" category. This award shines the light on Bosnalijek's efforts in environmental protection.
- Integrated Management System: Adhering to international standards such as ISO 9001, ISO 14001, ISO 45001, and ISO 13485, Bosnalijek ensures quality, environmental protection, and occupational health and safety across all its operations.
- Giving back to the community: Through numerous socially responsible activities, including partnerships with hospitals, NGOs, governmental institutions, Bosnalijek supports health, education, and the vulnerable population. Further, Bosnalijek supports public health programs, medical research, and initiatives to improve healthcare systems and pharmaceutical accessibility.
- Environmental protection: Bosnalijek invests in cutting-edge technologies that reduce emissions, optimize energy consumption, and minimize waste. The company is dedicated to water conservation, responsible resource use, and sustainable packaging solutions to mitigate its ecological footprint.
Bosnalijek at ESG Adria Summit 2025
As a Supporter of ESG Adria Summit 2025, Bosnalijek is reinforcing its role as a leader in sustainable healthcare. Adnan Hadžić, CEO of Bosnalijek reflected on that: "The ESG Adria Summit provides a critical platform for us to share our experiences and learn from other leaders in sustainable business. The pharmaceutical industry is undergoing a major shift, with sustainability becoming a defining factor for long-term success. We believe that by integrating ESG principles into our operations, we can contribute to a healthier planet and a more healthy society."
Biljana Braithwaite, CEO of Sustineri Partners, organiser of the Summit said: "Sustainability in healthcare is an urgent topic, and we are proud to have Bosnalijek as a partner in this conversation. Their efforts in building responsible pharmaceutical practices and ESG-driven innovation go hand in hand with our mission to drive long-term, future-proof business growth. Their presence at the Summit will help bridge the gap between sustainability and healthcare advancements, and inspire new collaborations in the region."
The Importance of Sustainability in the Pharmaceutical Industry
From shrinking carbon footprint in the production to securing ethical sourcing, pharmaceutical companies have a serious task at their hands - to align with global ESG and sustainability targets. This isn't just about ticking regulatory boxes, it's about tackling public health challenges and making vital medicines affordable. Plus, with the climate crisis looming, responsible practices aren't just good business – they're essential.
Specifically, this means:
- To minimize environmental impact through lean manufacturing and responsible waste handling;
- To ensure ethical supply chains;
- To drive innovative practices through strategic R&D investments;
- To cultivate healthy workplaces and communities.
Bosnalijek’s approach sets a regional example of how pharmaceutical companies embrace these principles without compromising innovation and growth.
